Case Study: Clinical trials for original drugs fall under
experimental use exception
In 2019, the University of Tokyo verified a high therapeutic effect in investigator-initiated clinical trials of a virus therapy for brain tumours.
It applied for manufacturing and selling approval of the first domestic cancer treatment viral drugs.
The ensuing case has clarified the rules around exceptions for experimental use in Japan, explains Takanori Abe of Abe & Partners.
Enter your details into the form to access this case study
Use the form to download the case study
Enter your details below to access the case study now
This report is produced by Abe & Partners and published by Newton Media. By registering to view the publication, you agree to share your contact information with both Newton Media and Abe & Partners. Full details of our privacy policy can be found here.
Brought to you in association with:
